tacrolimus (Samyang)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nametacrolimus (Samyang)

Drug Alias Nametacrolimusimmunosuppressant drug (Samyang)B6020

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCalcineurin inhibitors

TargetsCalcineurin

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSamyang Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSamyang Corp

Active IndicationsN/A

Inactive IndicationsAutoimmune Diseases

ATC CodeN/A